Journals / Turkish Journal of Medical Sciences / 2017 / Cilt: 47 - Sayı: 3

Rational design of rabies vaccine formulation for enhanced stability

Pages
987–995
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: Our results indicate that some viruses lose their stability and efficacy in the course of lyophilization if the pH of the cell culture medium is controlled by solvated CO2because the structure of the rabies virus is very sensitive to the solution pH: the virus either aggregates or its shape is deformed at low solution pH, whereas at high pH empty capsid shells are formed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: Vaccines are often lyophilized in order to retain their stability and efficacy for a longer period of time.
📊
Key Findings & Data:Results: Our results indicate that some viruses lose their stability and efficacy in the course of lyophilization if the pH of the cell culture medium is controlled by solvated CO2because the structure of the rabies virus is very sensitive to the solution pH: the virus either aggregates or its shape is deformed at low solution pH, whereas at high pH empty capsid shells are formed.
💡
Conclusion & Impact:Conclusion: Based on our findings, we developed a new formulation for the rabies vaccine that is stable in different buffers owing to the prevention of pH upshift upon lyophilization.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aim: Vaccines are often lyophilized in order to retain their stability and efficacy for a longer period of time. However, the same lyophilization process may also cause a major degradation of the vaccine, especially during early phases of manufacturing, leading to a loss of potency of the product. Many viral diseases, such as rabies, are acute and fatal unless the vaccine is administered prior to exposure or the onset of symptoms in the case of postexposure treatment. Materials and methods: We investigated the effect of lyophilization on the stability of the virus structure during rabies vaccine manufacturing using dynamic light scattering and transmission electron microscopy. Results: Our results indicate that some viruses lose their stability and efficacy in the course of lyophilization if the pH of the cell culture medium is controlled by solvated CO2because the structure of the rabies virus is very sensitive to the solution pH: the virus either aggregates or its shape is deformed at low solution pH, whereas at high pH empty capsid shells are formed. Conclusion: Based on our findings, we developed a new formulation for the rabies vaccine that is stable in different buffers owing to the prevention of pH upshift upon lyophilization.

🔖

Cite This Article

KAYSER, V., PINTON, H., SALUZZO, J., TROUT, B. L., FRANÇON, A. (2022). Rational design of rabies vaccine formulation for enhanced stability. Turkish Journal of Medical Sciences, Cilt: 47 - Sayı: 3, 987–995. https://ajindex.com/articles/610983

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Sellal F, Stoll-Keller F. Rabies: ancient yet contemporary cause of encephalitis. Lancet 2005; 365: 921-923
  2. Rupprecht CE, Hanlon CA, Hemachudha T. Rabies reexamined. Lancet Infect Dis 2002; 2: 327-343
  3. Crick J. Rabies virus genome. In: Kuwert E, Merieux C, Koprowski H, Bogel K, editors. Rabies in the Tropics. Berlin, Germany: Springer-Verlag; 1985. pp. 13-20
  4. Cox JH, Dietzschold B, Schneider LG. Rabies virus glycoprotein. II. Biological and serological characterization. Infect Immun 1977; 16: 754-759
  5. Dietzschold B, Cox J, Schneider G. Structure and function of rabies virus glycoprotein. Dev Biol Stand 1978; 40: 45-55
  6. Dietzschold B, Cox JH, Schneider LG, Wiktor TJ, Koprowski H. Isolation and purification of a polymeric form of the glycoprotein of rabies virus. J Gen Virol 1978; 40: 131-139
  7. Gaudin Y, Ruigrok RWH, Brunner J. Low-pH induced conformational changes in viral fusion proteins: implications for the fusion mechanism. J Gen Virol 1995; 76: 1541-1556
  8. Gaudin Y, Tuffereau C, Durrer P, Brunner J, Flamand A, Ruigrok R. Rabies virus-induced membrane fusion. Mol Membr Biol 1999; 16: 21-31
  9. Maillard A, Domanski M, Brunet P, Chaffotte A, Guittet E, Gaudin Y. Spectroscopic characterization of two peptides derived from the stem of rabies virus glycoprotein. Virus Res 2003; 93: 151-158
  10. Roche S, Gaudin Y. Characterization of the equilibrium between the native and fusion-inactive conformation of rabies virus glycoprotein indicates that the fusion complex is made of several trimers. Virology 2002; 297: 128-135
  11. Weissenhorn W, Hinz A, Gaudin Y. Virus membrane fusion. FEBS Lett 2007; 581: 2150-2155
  12. Madora H, England J. Rabies virus protein synthesis in infected BHK-21 cells. J Virol 1977; 22: 102-112
  13. Public Health England. Human Rabies Vaccines. London, UK: Public Health England
  14. Galazka A, Milstein J, Kartoglu U, Zaffran M. Temperature Sensitivity of Vaccines. WHO/IVB/06.10. Geneva, Switzerland: WHO; 2006
  15. Babiuk S, Skowronski DM, De Serres G, HayGlass K, Brunham RC, Babiuk L. Aggregate content influences the Th1/Th2 immune response to influenza vaccine: evidence from a mouse model. J Med Virol 2004; 72: 138-142
  16. Singh SK. Impact of product-related factors on immunogenicity of biotherapeutics. J Pharm Sci 2011; 100: 354-387
  17. Galazka A, Milstien J, Zaffran M. Thermostability of Vaccines. WHO/GPV/98.07. Geneva, Switzerland: WHO; 1998
  18. Dietzschold ML, Faber M, Mattis JA, Pak KY, Schnell MJ, Dietzscho